Hirschberg I , Frewer A (2009): Genetics, counseling and ethics. An introduction, in: Hirschberg et al. (eds.) Ethical Issues in Genetic Counseling: 9-21. Hirschberg I (2009): Genetic counseling and ethics. P [...] (2010): User testing of health information by the Institute for Quality and Efficiency in Health Care (IQWiG) Final report. Patients' University, Institute of Epidemiology, Social Medicine and Public Health [...] Practice 16: 1-18. doi:10.1177/26323524221083676. Krones T, Hirschberg I (2022): Preimplantation genetic diagnosis (PGD), in: Marckmann G (ed.). Praxisbuch Ethik in der Medizin , Berlin: MWV Medizinisch

Dr. Doris Steinemann, Institut für Humangenetik, MHH: 'Repetitive sequences in human genomes and their contribution to disease development' Prof. Dr. Hildegard Büning, Institut für Experimentelle Hämatologie [...] Department of Pneumology, MHH Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) 22.02.2023 REBIRTH colloquium (1 pm s.t., online lecture) ‘Genetic engineering of organs to support graft [...] Heisterkamp,Institut für Quantenoptik, LUH: ‘Biophotonics - Application of light in cells and tissues’ 10.03.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge) Prof. Dr. Axel Schambach, Institut für Ex

head of the Institute for Experimental Haematology at the Hannover Medical School (MHH), is developing RNA-based drugs to combat viral diseases in cooperation with the Fraunhofer Institute for Toxicology [...] "We have successfully tested the efficacy of our RNAi candidates on human lung tissue sections as well as in 3D cell cultures from human lung epithelium," explains Professor Dr. Armin Braun, Head of Preclinical [...] place on the viral RNA, thus making it unreadable and initiating its degradation. The result: the genetic blueprint packed in it is not implemented and virus replication is blocked. "In the meantime, we

therapy. Professor Dr. Dr. Axel Schambach, head of the Institute of Experimental Haematology at the Hannover Medical School (MHH), wants to genetically modify the immune cells in such a way that they detect [...] in the laboratory from “reprogrammed” adult body cells and can then produce any cell type in the human body – including NK cells of the innate immune system. The advantage: the NK cells can be produced [...] transplanted quickly and in unlimited numbers. But that is not enough. “The NK cells need to be genetically modified and put into a hyperactive and more targeted state, so that they can ensure greater targeting

organ nevertheless remains as small and effective as possible, as is the case with the human lung. In the human lung, about 100 to 140 square meters of breathing surface are packed into 300 million alveoli [...] artificial lungs can be transplanted into the human body. The DFG Priority Program SPP 2014 is funding a total of ten projects throughout Germany. The lead institutions are the Rheinisch-Westfälische Technische [...] g endothelial cells. "These endothelial cells, which are not endogenous to the body, are also genetically modified so that they are virtually invisible to the patient's immune system and are therefore

Toronto General Hospital Research Institute, University Health Network and Institute of Biomaterials and Biomedical Engineering, Toronto, Canada on the topic of Human Embryonic Stem Cell-Derived Cardiomyocytes [...] minimization of genetically variant stem cells in human pluripotent stem cell cultures Halloin, C., Hannover Medical School, Germany Chemically defined cardiomyogenic differentiation of human pluripotent stem [...] Weizman n Institute of Science, Israel The TECHNOBEAT consortium, under the lead of MHH and project partner KADIMASTEM, hosted the first official satellite meeting at the renowned Weizmann Institute of Science

disease models Final exam November 2005 Krishna Kumar Singh INDIA supervisor: Prof. Dr. Schmidtke, Human Genetics, OE 6300, project: Disease related variants of ARMD and functional implications Final exam June [...] Students of the year 2002 Diya Abraham INDIA supervisor: Prof. Eichele, Max-Planck Institute f. Experimental Endocrinology, project: Analyzing the in vivo function of Protein kinase C by using mutant mice [...] project: Generation and characterization of hematopoietic stem cell lines as novel tools to investigate genetic and developmental aspects of congenital bone marrow failure syndromes Final exam November 2006 Thomas

the Paul Ehrlich Institute are monitoring the four-year project. If everything goes as planned, the researchers hope, prerequisites for a clinical trial of cell-based heart repair in humans can subsequently [...] over Europe and Israel, with more than six million euros, of which the MHH as the coordinating institution is receiving 1.4 million euros. Bringing heart muscle cells to the target In many heart diseases [...] is impaired. Unlike in some amphibians and fish species, such damage is not repaired in an adult human heart. Scientists around the world are therefore working on strategies to replace destroyed heart

speaker! Lily Sophie Rose , GERMANY, Rose.Lily@mh-hannover.de Supervisor: Prof. Dr. Ruthhild Weber (Human Genetics) Project: Ribosomal biogenesis genes and predisposition to brain tumors Tirthankar Saha , INDIA [...] Wilson.Agyapong @ mh-hannover.de Supervisor: Dr. Natalie Weber, PhD / Prof. Dr. Dr. Thomas Thum (Institute of Molecular and Translational Therapeutic Strategies IMTTS and Fraunhofer ITEM) Project: Investigation [...] zebrafish Sedef Ersoy, GERMANY, Ersoy.Sedef @ mh-hannover.de Supervisor: Prof. Dr. Christian Bär (Institute of Molecular and Translational Therapeutic Strategies, IMTTS) Project: Elucidating the role of circRNAs

Martin Stanulla was born in Hanover in 1965. After completing his civilian service and studying Human Medicine at Hannover Medical School (MHH) and Harvard Medical School in Boston, USA, he began his [...] German Research Foundation and worked on a leukemia research project at the Roswell Park Cancer Institute in Buffalo. In Buffalo, he also studied epidemiology at the State University of New York and was [...] directly with clinical studies and to comprehensively characterize leukaemia patients on the basis of genetic characteristics in order to provide them with an optimally adapted therapy.